North Wales & Northwest Urological Research Centre, Betsi Cadwaladr University Health Board (BCUHB) Wrexham Maelor Hospital, Wrexham, Wales, UK.
Maelor Academic Unit of Medical and Surgical Sciences, Betsi Cadwaladr University Health Board (BCUHB) Wrexham Maelor Hospital, Wrexham, Wales, UK.
Eur J Med Res. 2022 Sep 26;27(1):187. doi: 10.1186/s40001-022-00807-8.
Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are the most common prostate disorders in the UK, which cause considerable ill health in older men. Transperineal template prostate biopsy (TTPB) has emerged as a reliable procedure for the histopathological diagnosis of PCa and BPH due to its higher cancer detection rates. Although antiseptic preparation and antibiotic prophylaxis are used to ensure safety in patients undergoing surgical intervention, post-operative complications, such as infection and bleeding are still unavoidable, resulting in re-admissions, with resource implications. Currently, there is no biomarker profile to predict outcomes or monitor patients during the post-operative course. The main aim of this single-centre observational clinical pilot-study was to investigate the role of inflammatory and infection biomarkers following TTPB and their association with post-operative complications.
Forty-five patients scheduled for elective TTPB were recruited after informed consent at the Wrexham Maelor and Glan Clwyd Hospitals, North Wales, UK (n = 45). Prior to surgery, venous blood samples were collected at baseline and subsequently at 30, 120, and 240 min post-operatively. Urine samples were collected before and 120 min after the procedure. Serum procalcitonin (PCT), serum ferritin, and urine BMG analysis were done using enzyme-linked fluorescent assay (ELFA) and the magnetic Luminex multiplex performance assay was used to analyse IL-6, IL-8, IL-10 and TNF-α plasma concentrations. Data on clinical outcomes were collected from patients' medical records.
Following TTPB, significant (p ≤ 0.05) increases were observed in uBMG, IL-6, IL-8, IL-10 and TNF-α. Significant decreases were observed in ferritin (p ≤ 0.05). No significant change was observed in PCT concentration (p ≥ 0.05). One patient developed an infection and severe haematuria post-operatively following TTPB.
Although not confirmative, changes seen in biomarkers such as uBMG, IL-10 and TNF-α in our observational clinical pilot-study may warrant further investigation, involving larger cohorts, to fully understand the role of these biomarkers and their potential association with post-operative complications such as infection and bleeding which can develop following TTPB for the diagnosis of PCa and BPH.
前列腺癌(PCa)和良性前列腺增生(BPH)是英国最常见的前列腺疾病,它们会给老年男性带来相当大的健康问题。经会阴模板前列腺活检(TTPB)由于其更高的癌症检出率,已成为 PCa 和 BPH 组织病理学诊断的可靠方法。尽管在接受手术干预的患者中使用了消毒准备和抗生素预防措施来确保安全,但术后并发症,如感染和出血仍然不可避免,导致再次入院,这会带来资源方面的影响。目前,尚无生物标志物谱可用于预测术后结果或监测患者。本单中心观察性临床试点研究的主要目的是研究 TTPB 后炎症和感染生物标志物的作用及其与术后并发症的关系。
在英国北威尔士雷克瑟姆梅勒和格兰克里德医院,经患者知情同意后,招募了 45 名计划接受选择性 TTPB 的患者(n=45)。手术前,在基线时和术后 30、120 和 240 分钟时采集静脉血样本。手术前和手术后 120 分钟采集尿液样本。使用酶联荧光分析(ELFA)检测血清降钙素原(PCT)、血清铁蛋白和尿液 BMG 分析,使用磁 Luminex 多重性能分析检测 IL-6、IL-8、IL-10 和 TNF-α 血浆浓度。从患者的病历中收集临床结果数据。
TTPB 后,uBMG、IL-6、IL-8、IL-10 和 TNF-α 显著升高(p≤0.05)。铁蛋白显著降低(p≤0.05)。PCT 浓度无显著变化(p≥0.05)。1 例患者在 TTPB 后出现感染和严重血尿。
虽然不是确认性的,但我们的观察性临床试点研究中观察到的 uBMG、IL-10 和 TNF-α 等生物标志物的变化可能需要进一步研究,涉及更大的队列,以充分了解这些生物标志物的作用及其与术后并发症(如感染和出血)的潜在关联,这些并发症可能在 TTPB 诊断 PCa 和 BPH 后发生。